title: [Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: contributing factors and long-term prognostic impact].
abstract: OBJECTIVE
  To elucidate the relative factors and prognostic impact for angiographic no-reflow phenomenon during primary percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI).
  
  
  METHODS
  A total of 930 patients with AMI who underwent primary PCI were divided into no-reflow group and normal-reflow group. Factors related to no-reflow were analyzed by logistic regression model and major adverse cardiac events (MACE) in-hospital as well as during long-term follow-up was also observed.
  
  
  RESULTS
  No-reflow occurred in 82 out of 930 patients. Admission glucose level (9.8 +/- 4.3 mmol/L vs. 8.5 +/- 3.5 mmol/L, P = 0.001), peak CK-MB value (369.4 +/- 167.8 U/L vs. 282.3 +/- 161.7 U/L, P < 0.01) and percentage of TIMI flow grade 0 on initial angiogram (69.5% vs. 54.5%, P = 0.009) were significantly higher and pre-infarction angina (19.5% vs. 48.1%, P < 0.01) was significantly lower in no-flow patients than normal flow patients. Logistic regression analyses showed that admission glucose level, absence of pre-infarction angina, TIMI flow grade 0 on initial angiogram and pump failure were independent predictors of no reflow. In-hospital MACE (37.8% vs. 11.3%, P < 0.01) and follow-up MACE (37.5% vs. 17.4%, P < 0.01) were also significantly higher in no-flow patients than normal flow patients. Multivariate Cox regression analysis revealed that no-reflow was an independent predictor of long-term cardiac death (relative risk 3.83, 95% confidence interval 1.71 to 5.57).
  
  
  CONCLUSIONS
  Admission glucose level, absence of pre-infarction angina, TIMI flow grade 0 on initial angiogram and pump failure were independent risk factors for no-reflow and no-flow is an independent predictor for increased in-hospital and follow-up MACE.
authors.affiliation: Department of Cardiology, General Hospital of Shenyang Military Region, Shenyang 110016, China. hanyal@mail.sy.ln.cn
authors.forename: Ya-ling
authors.initials: YL
authors.lastname: Han
authors.forename: Jie
authors.initials: J
authors.lastname: Deng
authors.forename: Quan-min
authors.initials: QM
authors.lastname: Jing
authors.forename: Shou-li
authors.initials: SL
authors.lastname: Wang
authors.forename: Ying-yan
authors.initials: YY
authors.lastname: Ma
authors.forename: Bo
authors.initials: B
authors.lastname: Luan
mesh_terms: D000368:Aged; D000787:Angina Pectoris; D015906:Angioplasty, Balloon, Coronary; D001786:Blood Glucose; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000628:therapy*; D011379:Prognosis; D016896:Treatment Outcome
chemical_list: D001786:Blood Glucose